Does Dr. TANIA GONZALEZ SANTIAGO have financial conflicts of interest?

Dr. TANIA GONZALEZ SANTIAGO (MD) has received a total of $207,841 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $201,891 in personal promotional payouts (consulting, meals, travel) and $5,950 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. TANIA GONZALEZ SANTIAGO?

According to CMS Open Payments data, Dr. TANIA GONZALEZ SANTIAGO received funding from GENZYME CORPORATION ($110,538), LILLY USA ($79,753), and ELI LILLY AND COMPANY ($7,601).

Does Dr. TANIA GONZALEZ SANTIAGO receive research grants or speaking fees?

Dr. TANIA GONZALEZ SANTIAGO has received $201,891 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $5,950 in clinical research grants.

DR. TANIA GONZALEZ SANTIAGO

MDReal-Time Hydrated

Specialty: Dermatology, Dermatopathology

Practice Location: CAGUAS, PR 00725

NPI Number: 1952539223

LIFETIME INDUSTRY VALUE

$207,841

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. GONZALEZ SANTIAGO is a verified Dermatology, Dermatopathology practitioner based in CAGUAS, PR.

Between 2021 and 2025, Dr. GONZALEZ SANTIAGO had an overall industry promotional and research financial footprint of $207,841 as recorded in the federal CMS Open Payments database.

$201,891 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$5,950 was allocated to sponsored clinical trials and medical research activities.

Dr. GONZALEZ SANTIAGO's primary funding source is GENZYME CORPORATION, which accounts for $110,538 (representing 53.2% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GENZYME CORPORATION

Rank 1

$110,538

53.2%

LILLY USA

Rank 2

$79,753

38.4%

ELI LILLY AND COMPANY

Rank 3

$7,601

3.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.